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Transplantation of neural progenitors derived from human embryonic stem cells (hESCs) provides a potential therapy for
ischemic stroke. However, poor graft survival within the host environment has hampered the beneﬁts and applications of cell-
basedtherapies.ThepresentinvestigationtestedapreconditioningstrategytoenhancehESCtolerance,therebyimprovinggraft
survival and the therapeutic potential of hESC transplantation. UC06 hESCs underwent neural induction and terminal
differentiation for up to 30 days, becoming neural lineage cells, exhibiting extensive neurites and axonal projections, generating
synapses and action potentials. To induce a cytoprotective phenotype, hESC-derived neurospheres were cultured at 0.1%
oxygen for 12h, dissociated and plated for terminal differentiation under 21% oxygen. Immunocytochemistry and
electrophysiology demonstrated the ‘hypoxic preconditioning’ promoted neuronal differentiation. Western blotting revealed
signiﬁcantly upregulated oxygen-sensitive transcription factors hypoxia-inducible factor (HIF)-1a and HIF-2a, while producing a
biphasic response within HIF targets, including erythropoietin, vascular endothelial growth factor and Bcl-2 family members,
duringhypoxiaandsubsequentreoxygenation.Thiscytoprotectivephenotyperesultedina50%increaseinbothtotalandneural
precursor cell survival after either hydrogen peroxide insult or oxygen–glucose deprivation. Cellular protection was maintained
for at least 5 days and corresponded to upregulation of neuroprotective proteins. These results suggest that hypoxic
preconditioning could be used to improve the effectiveness of human neural precursor transplantation therapies.
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Stroke is a devastating disease afﬂicting B700000 people
every year within the United States and causing about 150000
deaths.
1 Despite extensive research on the mechanism and
treatmentofstroke,verylimitedeffectivetherapiesareavailable
for stroke patients. Current consent agrees that, in addition to
the application of neuroprotective strategies, neuroregenerative
therapies involving endogenous or exogenous approaches
should be explored for repairing ischemia-damaged brain
regions. In this regard, recent studies have demonstrated the
potential for transplantation of neural progenitors derived
from human embryonic stem cells (hESCs) to ameliorate the
structural and behavioral deﬁcits associated with cerebral
ischemia animal models.
2 Recent FDA clearance for the ﬁrst
Phase I clinical trial use of hESC transplantation therapy
provides increasing expectation for hESC therapies.
3
In stem cell therapy for strokes, a key step is the neural
differentiation of pluripotent stem cells. Mouse ES cell can
differentiate into neuronal and glial lineage cells, both in vitro and
following transplantation into the ischemic brain.
4,5 Consistent
with their pluripotency, neuronal and non-neuronal differentiation
ofhumanEScellswerealsoshowninvitroandinvivo.
6However,
there have been fewer direct demonstrations of functional
activities of hESC-derived neuronal cells.
5–7 In the present
investigation, we examined neuronal differentiation of hESCs
using both morphological and electrophysiological methods.
An issue limiting the clinical application and effectivenessof
stem cell therapies is the high rate of transplanted cell death.
Graft survival within the ischemic core and peri-infarct regions
following stroke is threatened by the release of excitotoxic
neurotransmitters/factors, free radical generation and secretion
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8Research on grafted cells shows
30–90% cell death within a few days of transplantation.
4,9,10
Human neural precursor transplantation studies following
ischemia concur, with reports of 60–90% graft cell death.
11,12
Cell death of transplanted cells not only hampers the efﬁciency
of the therapy, it also introduces an additional burden to the
post-ischemic brain already compromised by a cellular debris
load.
13 Therefore, the development of novel strategies to
enhance cell viability after transplantation is urgently important
for more effective and efﬁcient stem cell-based therapies.
Hypoxic or ischemic preconditioning was initially discov-
ered as an endogenous protective mechanism in animals and
later conﬁrmed in virtually all types of cultured cells and
organs.
14,15 In general, one or a series of sublethal hypoxic or
ischemic insults can markedly enhance the tolerance of
treated subjects to a consequent more severe insult. Hypoxic/
ischemic preconditioning usually produces two phases of
cytoprotection:PhaseI,anacuteprotectionthatappearsearly
and lasts for a few hours after insult and Phase II, a delayed
but stronger protection which emerges many hours after
hypoxiaandcanlastfordaysorevenweeks.
14,15 Thedelayed
phase of hypoxic/ischemic preconditioning is mediated by
synthesis of mRNAs and proteins, including the transcription
factor hypoxia-inducible factor 1-a (HIF1-a) and HIF target
genes, such as erythropoietin (EPO) and vascular endothelial
growth factor (VEGF).
14,15 Our recent work demonstrated
the prosurvival effects of hypoxic preconditioning on mouse
ES cell-derived neural precursors and mesenchymal stem
cells.
16,17 Neurally induced mouse embryoid bodies cultured
in 1% oxygen for 8h exhibited increased tolerance to serum
deprivation in vitro and enhanced survival after transplanta-
tion to the ischemic rodent brain and heart.
16,17 More
importantly, transplantation of preconditioned cells showed
superiorabilityofimprovingfunctionalrecovery.Otherstudies
have shown that hESCs cultured in low oxygen tensions
comparable with the levels observed in the mammalian
reproductive tract and the brain (1–5%) exert signiﬁcant
effects on cellular proliferation, pluripotency and maintenance
of chromosomal stability.
18 In fact, the physiological oxygen
tension within the gray matter of the rat cerebral cortex was
measured to range from 2.5 to 5.2% (19–40mmHg), well
below standard hESC culture conditions (21% O2).
19 On the
basis of these ﬁndings, we proposed that under a low oxygen
culture condition, hESCs should still be able to differentiate
normally and meanwhile acquire enhanced tolerance to
injurious insults. The increased trophic factors promoted by a
sublethal hypoxia should bring out additional beneﬁts such as
stimulating neurogenesis and angiogenesis in the host tissue.
Results
hESC neurospheres and directed neural differentiation. The
bone morphogenic protein (BMP) family signaling promotes
embryonic stem cell self-renewal, while at the same time
promotes mesodermal and trophoblast differentiation instead of
neural differentiation.
20,21 hESC supplementation with BMP
antagonist Noggin and bFGF produced a predominantly
neuronal cell phenotype with extremely low expression of
pluripotent, mesodermal and endodermal-speciﬁc genes.
22
For our studies, we chose to direct hESCs to a neural phenotype
using an established protocol with some modiﬁcations.
22
Culture of the UCO6 hESC line on a mouse embryonic
ﬁbroblast (MEF) feeder layer allowed for efﬁcient growth of
undifferentiatedbutpluripotentcolonies,evidencedbycellular
morphology and immunostaining for pluripotent cell surface
markers (Figure 1a–d). hESCs might acquire chromosomal
abnormalities through enzymatic passage, particularly
aneuploidy, trisomy 12 and trisomy 17.
23 To prevent this, we
eliminated enzymatic passaging and opted for manual
dissection to better maintain chromosomal stability. Standard
Giemsa banding analysis demonstrated that manual dissec-
tionpreventedchromosomalabnormalities,sustainingnormal
cell karyotype for up to 75 passages (Figure 1e).
To induce neural differentiation, manually isolated colonies
wereculturedasﬂoatingneurospheresfor42days(Figure1f).
After plating for adhesion, polarized individual cells migrated
outward from the spherical center after 24h (Figure 1g). After
7 and 14 days, cell body size and projection length increased;
by 21 days cellular projections increased not only in size but
also in density. Individual cells displayed multiple neurite
outgrowths and dendritic spines, characteristics typical of an
immature neuronal phenotype (Figure 1h–j).
To verify that the differentiating cells were neural in nature,
immunostaining was performed at various stages of develop-
ment. Twenty-four hours after plating, the majority of cells
were positive for the neural precursor protein nestin
(87.2±1.97%). Importantly, cells positive for the pluripotent
cell surface antigen stage-speciﬁc embryonic antigen 4
(SSEA-4) were virtually non-existent (Figure 2a). Beginning
on day 3 of terminal differentiation, expression of the medium
length neuroﬁlament polypeptide (NF-M), a neuronal-speciﬁc
protein marker expressed by mature neurons, can be
observed in a portion of differentiating cells (Figure 2b).
Neuronal maturation continued and by 7 days, the neuronal
protein markers bIII-tubulin and NeuN were expressed in
76.98±5.7 and 48.19±1.8% of total cells, respectively,
indicating the formation of a neuronal cell population
(Figure 2c). Allowing cells to differentiate for longer time
periods lead to increased neural maturation. After 21 days,
72.7±4.2% of cells were positive for NF-M (Figure 2f and g).
Also, many broad axonal structures were positive for both
NF-M and the neuronal-speciﬁc protein microtubule-associated
protein-2 (MAP2; Figure 2f and g). Twenty-eight days after
beginning terminal differentiation, some axonal projections
expressed myelin-binding protein (MBP), suggesting axonal
myelinationandsheathformation(Figure2h).Glialcellspositive
to glial ﬁbrillary acidic protein (GFAP) and the oligodendrocyte
marker O4 were observed after 7-day differentiation. GFAP
was expressed in 19.2±2.4% of all cells, while O4-positive
cells were rarely observed (Figure 2d and e). Glial prolifera-
tion continued after a month differentiation, likely providing
enhanced trophic supports for maturing neurons. To some
extent, this mixed culture provides an environment mimicking
in vivo cell compositions (Figure 2i).
Functional expression of voltage- and ligand-gated
channels in hESC-derived neurons. To verify that
neuron-like cells derived from hESC-derived neurospheres
were physiologically active, patch clamp whole-cell recording
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Cell Death and Diseasewas performed on cells at various stages of maturation. In cells
undergoing 21 days terminal differentiation, stepwise depolarizing
pulses from a holding potential of  70mV evoked a rapidly
activating/inactivating inward current and a steady outward
current of increasing amplitudes (Figure 3a). Addition of 500nM
tetrodotoxin (TTX) to the extracellular solution abolished the
inward current, corroborating the expression of TTX-sensitive
sodium channels, INa, in these cells (Figure 3b).
In the presence of TTX, membrane depolarization triggered
sustained outward currents in most cells, containing both a
fast inactivating (outlined by rectangular box) and a slow
inactivating outward current (Figure 3c). The broad spectrum
potassium channel blocker tetraethylammonium bromide
(TEA; 10mM) inhibited both fast- and slow-inactivating
outward currents, indicating that these were TEA-sensitive
K
þ currents (Figure 3d). Addition of 4-aminopyridine (5mM)
selectivelyblockedthefast-inactivatingcurrent(Figure3eand
f), further suggesting the existence of the A-type K
þ current,
IA, in these cells. Using current–voltage plots of both INa and
IK, determination of half-maximal currents indicated that both
these two currents showed typical voltage-dependent activa-
tions (Figure 3g and h). All three currents showed time-
dependent increases during neuronal maturation (Figure 3i).
Immunohistochemical staining and whole-cell recording
were applied to detect glutamate receptors and synapto-
genesis in differentiating cells (Figure 3j–l). The glutamate
receptor subtype-speciﬁc agonist N-methyl-D-aspartic acid
(NMDA)ora-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) was locally applied to hESC-derived cells under
whole-cell voltage clamp. Administration of 200mM NMDA
and 10mM glycine elicited an inward current in 43% of cells 28
days into differentiation, with peak current of 843±329pA
and steady state current of 698±294pA (n¼14, Figure 3m).
Similarly, 45% of these cells exhibited a fast inactivating
inward current (peak current¼201±30pA) in response to
application of 100mM AMPA (n¼11, Figure 3m).
Miniature postsynaptic currents (mPSCs), measures of
spontaneous release and subsequent uptake of neurotrans-
mitters at the synaptic cleft, were recorded in hESC-derived
cells. After 35 days into terminal differentiation, most cells
of neuronal morphology exhibited an extensive number of
spontaneous inward events (Figure 3n). A comparison of
28- and 35-day measurements revealed an increase in both
the frequency of events (0.85±0.10 versus 2.22±0.35) and
the mean peak amplitude (21.32±0.14 versus 29.92±0.34)
over time.
Figure 1 Neuraldifferentiationof UCO6 hESCs.(a) Typicalcolonyof hESCs(passage70).(b–d) Colonies express pluripotent markersTRA-1-60(b) and SSEA4(c), but
arenegativeforSSEA-1(d).(e)Normalkaryotypicanalysisofpassage75UCO6colonies.(f)Twenty-eightdayﬂoatingneurosphere(B200mminsize).(g–j)Afterbeginning
terminal differentiation, cells exhibit increasingly neural morphology after 1 day (g), 7 days (h) and 14 days (i). Cells exhibit signiﬁcant neuritic extensions and dendritic spine
formation (white arrows) after 21 days terminal differentiation (j)
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Cell Death and DiseaseHypoxic preconditioning increases the tolerance of
hESC-derived cells. To induce a cytoprotective phenotype
of hESC-derived neural cells, neurospheres were cultured for
41 days at 21% oxygen and then placed in 0.1% oxygen for
different hours. The hypoxia procedure up to 72h did not
cause signiﬁcant cell death measured by Trypan blue uptake
in gently dissociated neurospheres immediately after
hypoxia. Cultures of neural precursors in 0.1% oxygen for
Figure 2 Neural gene expression in differentiating hESC-derived neural progenitor cells. (a) Cells exhibit high expression of the neural precursor marker nestin (green)
and very low expression of SSEA-4 (red) 1 day after cell adhesion. (b and c) Three days into terminal differentiation, nestin (green) positive, elongated cells begin to express
medium chainneuroﬁlament (NF-M; red). (d) Seven days after plating, the neuronal markers bIII-tubulin (green) and NeuN (red) were highly expressed. (e) Expression of the
astrocyte marker GFAP is observed after 7 days. (f) Very few O4-positiveimmunoreactive cells were found in these cells. (g and h) Extensive NF-M (green) and microtubule-
associate protein-2 (MAP2; red) immunoreactive projections were present in cells of at 21 days into differentiation. (i) Twenty eight days after plating, some projections are
positive for myelin-binding protein (MBP), indicating axonal myelination. (j) Extensive beds of GFAP-positive astrocytes can also be observed after 28 days into terminal
differentiation. All blue staining indicates Hoechst-positive nuclei
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Cell Death and DiseaseFigure 3 Neuronal channel and synaptic activities in hESC-derived neurons. (a) Depolarization steps from a  70mV holding potential induced rapidly activating inward
currents followed by slow inactivated outward currents. (b) Administration of 500nM TTX completely blocked the inward current, conﬁrming its Na
þ current nature. (c) The
current–voltage relationship of Na
þ currents in 7- (closed triangles) and 21-day (open triangles) differentiating cells. (d) In the presence of TTX, most cells showed fast- and
non-inactivatedoutwardcurrents.ThefastinactivatingIAcurrentisoutlinedbyarectangularbox,whiletheapproximatestartofsteadystateIKislabeledwithanarrow.(e)The
application of 10mM TEA attenuated both outward currents, consistent with the sensitivity of K
þ channels to TEA. (f) The I–V relationship of the IK current in hESC-derived
neuron-like cells 7 days (closed triangles) and 21 days (open triangles) in differentiation. (g and h) Block of the fast outward currents by 4-aminopyridine, suggesting the
existenceoftheIAcurrentinthesecells.(i)SummarygraphofpeakcurrentofINa,IKandIA.*Po0.05between7and21days;
#Po0.05between14and21days.(j)After28-
day terminal differentiation, expression of NMDA receptors was indicated by immunostaining of the NR1 subunit in hESC-derived cells. (k) Extensive expression of the
synaptic vesicle protein synaptophysin can be observed overlaying with NF-M after 28 days in differentiation. (l) Higher magniﬁcation image shows punctate expression of
synaptophysinindifferentiatedcells.(m)Patchclampwhole-cellrecordingsoncellsof28-dayneuraldifferentiationrevealedfunctionalNMDA(left)andAMPA(right)currents.
(n) Representative trace shows spontaneous miniature potentials over a 2min recording in cell after 35-day differentiation
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Cell Death and Disease12h showed a reduction in spontaneous cell death of Trypan
blue-positive cells compared with 21% oxygen maintained
controls (21.6±3.0 versus 41.4±1.8%; n¼4 separate
experiments). This early protective effect was transient,
disappearing after 24-h hypoxic culture when basal cell death
between hypoxic and normoxic groups was comparable
(32.4±2.5 and 41.4±1.8%; n¼4). We therefore determined
that a 12-h exposure to 0.1% oxygen induced a rapid phase
of preconditioning.
Wenextdeterminedwhetheraprolonged,delayedphaseof
preconditioning could be initiated in human neural cells. To
induce delayed Phase II preconditioning, cells received an
initial hypoxic exposure, followed by return to 21% oxygen for
up to 5 days. Cells were then challenged with a lethal insult
common to cerebral ischemia: hydrogen peroxide (H2O2;
500mM)) or glucose and oxygen deprivation (OGD). Control
hESC-derived neural cells exhibited high expression of nestin
and few terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP nick end labeling (TUNEL)-positive nuclei
(Figure 4a). After 24-h H2O2 treatment, non-preconditioned
cells showed extensive numbers of TUNEL-positive nuclei,
whereas cells that received preconditioning were more
Figure 4 Hypoxic preconditioning enhances cellular tolerance to lethal insults. (a) Neural precursors stained with Hoechst (blue) and nesting (red), there are very few
TUNEL-positive(green)cells,suggestinghighviabilityunderour controlcondition.(bandc)Theinsult ofhydrogenperoxide(H2O2, 500mM) inducedsigniﬁcantlycelldeathin
cultures with normoxic condition (b), exhibited as increased TUNEL-positive cells. On the other hand, hypoxic-preconditioned cells showed high resistance to the same insult
(c). (d and e) TUNEL-positive cells induced by H2O2 or oxygen glucose deprivation and their co-labeling with Hoechst (all cells) or nestin (neural progenitors) at different days
after termination of the 12-h hypoxic pretreatment. Total cell death (TUNEL/Hoechst colocalization) and neural precursor cell death (TUNEL/nestin colocalization) were
signiﬁcantly reduced in preconditioned cultures after H2O2 treatment (d) or oxygen glucose deprivation (e). *Po0.05 versus normoxic culture
Preconditioning of human neural precursors
KR Francis and L Wei
6
Cell Death and Diseaseresistant to H2O2-induced death and maintained membrane/
nuclear integrity (Figure 4b and c). Quantiﬁcation of
TUNEL-positive cells conﬁrmed increased survival of
preconditioned neural cells compared with non-precondi-
tioned cells 3 and 5 days after reoxygenation (Figure 4d).
Preconditioned cells were also more tolerant to OGD than
non-preconditioned cells, displaying a B50% reduction in
total and neural precursor cell death 3 and 5 days after
reoxygenation (Figure 4e).
Previous studies have shown that culture conditions below
5%oxygencanenhanceproliferationofneural andembryonic
stem cells.
24,25 Increased cellular proliferation after hypoxia
couldpartlyaccountforincreasedcellcounts.Toevaluatethis
possibility, cells were pulsed overnight with bromodeoxy-
uridine (BrdU) that can incorporate into newly synthesized
DNA of proliferating neural cell types.
26 Immunocytochemical
analysis of BrdU uptake after 3 days showed that both
normoxic and hypoxic nestin-positive cells were highly
proliferative (46.8±9.4 versus 53.2±7.9, respectively).
No statistical difference was observed between these two
groups (P¼0.41). Immunostaining also showed very
little proliferation of non-nestin-positive cells in both groups
(o1% of total cells), further conﬁrming the formation
of a neurogenic, non-pluripotent cell population under our
experimental condition.
Time course experiments showed no cellular protection
within 24h after reoxygenation in hypoxia-treated cells. This
observation was consistent with the notion that Phase II
protection requires a time-dependent process of gene
regulation.
14,15 To verify this, protein and mRNA levels of
cytoprotective and cell death associated genes after pre-
conditioning were compared with normoxic controls. RT-PCR
analysis showed that HIF1-a mRNA levels were increased
after only 3-h culture at 0.1%, with much greater mRNA after
12- and 24-h hypoxic exposure (Figure 5a). The mRNA
expression of the Bcl-2 family gene BNIP3, an HIF1-a target
linked to delayed neuronal death through stabilization of p53
tumor suppressor during chronic hypoxia, was reduced
(Figure 5a). On the other hand, elevated HIF1-a mRNA levels
were maintained for at least 24h after returning to 21%
oxygen (Figure 5a). At the protein level, we observed HIF1-a
and HIF2-a stabilization and upregulation after 12-h hypoxic
culture (Figure 5b). Increased activation of the MAP kinase
Akt by phosphorylation at Ser 473 was also observed by 3-h
hypoxic culture and remained elevated on reoxygenation,
along with increases in hypoxia-responsive proteins EPO and
Figure 5 Hypoxic preconditioning induced gene regulation. (a) The HIF1-a mRNA level in hESC neurospheres was upregulated after 3–24h under the 0.1% oxygen
condition, revealed by RT-PCR measurements. The last column shows that the HIF1-a level remained high after ﬁnishing a 12-h hypoxia plus 12-h back to 21% oxygen
(reoxygenation). No change in the expression of the proapoptotic gene BNIP3 was observed. b-Actin was used as a loading control. (b) Western blot analysis shows the
upregulation of the protein levels of HIF1-a and pAkt induced by the hypoxia treatment. The Akt activation (phosphorylation of S473) was inhibited by the PI3K inhibitor
Wortmannin that also partially inhibited hypoxic stabilization of HIF1-a.( c) Western blot analysis showed signiﬁcant upregulation of several survival genes, including HIF1-a,
HIF2-a, pAkt, EPO and Bcl-2 after the 12-h 0.1% oxygen treatment. a-Tubulin was used as a loading control. (d) Gene regulation after the termination of hypoxic treatment.
Different time points after hypoxia, cells were returned to 21% oxygen. The protective gene bcl-2 decreased and proapoptotic gene Bax increased after reoxygenation.
However,a signiﬁcant upregulation of EPO, matureVEGF andBcl-2,as well as a downregulation of Bax, wereevident after72-h reoxygenation. *Po0.05 betweennormoxic
controls and 12-h hypoxic culture; **Po0.05 between normoxic controls and 72-h reoxygenation
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Cell Death and DiseaseBcl-2 (Figure 5c). Protein upregulation appeared later for
EPO, EPO receptor (EPOR), Bcl-2 and VEGF (Figure 5c).
Consistent with the lack of protection 24h after returning to
21% oxygen, the gene expression pattern displayed a shift
away from cytoprotection at this time, as evidenced by the
downregulation of EPO and Bcl-2 levels concurrent with
upregulation of Bax (Figure 5d). However, at 72-h time point a
subsequent re-elevation of measured cytoprotective proteins
(EPO, 42kDa-VEGF, Bcl-2) and decline in apoptotic factors
such as Bax was evident (Figure 5d). Seventy two hours after
return to 21% oxygen, EPO and VEGF expression was
increased to 58.5±0.11 and 39.6±0.12%, respectively
(Po0.05, n¼3), whereas the Bcl-2/Bax ratio increased
44.2±0.14% compared with non-preconditioned levels
(Po0.05, n¼3). These ﬁndings show a biphasic protein
response after preconditioning directly corresponding to
observed cytoprotection.
Whether HIF1-a stabilization is dependent on phospho-
inositide 3-kinase (PI3K)/Akt signaling is a matter of
question.
27,28 During this study, we observed a signiﬁcant
upregulation of phospho-Akt before HIF1-a stabilization
(Figure 5b). To test whether Akt activation regulates HIF
stabilization, the PI3K inhibitor Wortmannin (1mM) was added
to cells concurrent with the initiation of 12-h hypoxic culture.
Protein analysis revealed that PI3K inhibition by Wortmannin
completely attenuated Akt phosphorylation and reduced
HIF1-a protein levels by B23% (Figure 5b).
Preconditioning increases the neurogenic capacity of
human neural precursors. Finally, we wanted to ascertain
whether the hypoxic preconditioning affected the neurogenic
or functional potential of hESC-derived progenitor cells. To
test this, cells were given the preconditioning stimulus, plated
and analyzed after 7 days of neural differentiation by
immunocytochemistry (Figure 6a). Preconditioned cells
exhibited a signiﬁcantly higher percentage of NeuN-positive
cells compared with non-preconditioned controls (58.65±5.4
versus 48.19±1.8; Po0.05; Figure 6b). No signiﬁcant
differences in GFAP-positive cells were observed between
normoxic and preconditioned groups (Figure 6b).
To determine the effects of hypoxic preconditioning on
generation of action potentials, cells of 7 and 21 days in
differentiation were analyzed using current clamp recordings.
Compared with 7-day cells, evoked spikes of 21-day cells
showed increasing amplitude, decreasing width and greater
numbers of events per depolarization (Figure 6c). Statistical
analyses revealed no signiﬁcant difference in amplitude,
frequency or half-width of action potentials between precondi-
tioned and non-preconditioned cells (Figure 6d–f).
Figure 6 Hypoxic preconditioning increases hESC neuronal differentiation. (a) Immunocytochemistry of normoxic (left panel) and preconditioned (right panel) cells
7 days into terminal differentiation. Both showed high expression of neuronal and astrocyte markers NeuN (green) and GFAP (red). Hoechst (blue) indicated total cells.
(b) Quantiﬁcation of neuronal (NeuN/Hoechst colocalization) and glial (GFAP/Hoechst colocalization) lineage cells after 7 days differentiation. The bar graph shows
preconditioning (gray bars) increased neuronal yield (NeuN-positive cells) compared with normoxic controls (blue bars). (c) Representative action potential traces evoked by
injection of 30pA current show functional activity of derived neurons over a 21-day period. (d and e) The amplitude and number of evoked action potentials signiﬁcantly
increased from 7 to 21 days in both normoxic (blue bars) and preconditioned cells (gray bars). Preconditioned cells showed a trend of increased size and number of action
potentials.(f)Action potentialhalf-widthwas signiﬁcantlyreducedin bothnormoxic andpreconditioned cells. Preconditionedcellsshoweda trendof sharper actionpotentials.
* and **Po0.05 compared with 7-day cells
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Cell transplantation therapy using pluripotent embryonic stem
cells is an imperative component of the potential regenerative
medicine. To fulﬁll the goal of cell replacement after ischemic
stroke, cell survival and directed neural differentiation to
speciﬁc functional neural cell types after engraftment are two
key steps. Although priming cells before transplantation has
received increased attention,
16,17,29 harnessing this pheno-
menon for use in human neural precursors has not been
explored. To the best of our knowledge, this is the ﬁrst report
of the effects of hypoxic preconditioning on hESC-derived
neural precursors. We show in this present investigation that
the preconditioning strategy with sublethal hypoxia is an
effective way of promoting survival of human ES cell-derived
neural progenitors. Previous research has shown neuronal
differentiation and maturation of mouse or human ES cells in
vitro and after transplantation,
6 but little evidence is available
so far to demonstrate functional neuronal activities, such as
actionpotentialgenerationandspontaneousneurotransmitter
release in neurally differentiating hESCs. Our investigation
provides evidence that neuronal cells derived from hESCs not
only develop neuronal morphology, but also exhibit mem-
brane excitability typical of glutamatergic neurons.
The present investigation shows that brief exposure of
human neural precursor cells to hypoxic conditions can
signiﬁcantly enhance cellular tolerance to consequent lethal
insults. This cytoprotective phenotype is maintained for at
least 5 days after the hypoxic stimulus, thereby promoting cell
survival during the critical acute phase after transplantation,
during which 30–90% of transplanted cells succumb to
environmental stresses within the host milieu.
4,11,12 We also
show that hypoxic preconditioning does not increase neural
precursor proliferation or detrimentally affect neuronal differ-
entiation. Both control and preconditioned hESC-derived cells
exhibit functional maturation of voltage and ligand-gated
currents as well as action potential generation.
In ES cells, HIF2-a increases Oct-4 expression, reduces
cell differentiation and may promote tumor formation.
30
Although our results found upregulation of hypoxia-regulated
genes, including HIF a-subunits and pAkt, we did not observe
enhanced proliferation after preconditioning. This could be
due to the brief hypoxic exposure used (12h in our study
versus 72h in above investigations). Supporting this idea, it
was shown that mRNA expression of the mitogen FGF-8 in
neural stem cells was not increased until 4 days of hypoxic
culture.
25 VEGF signaling through HIF1-a was previously
demonstrated as a requirement for neural precursor prolifera-
tion.
31Inthepresentinvestigation,VEGFwasnotupregulated
until cells were returned to 21% oxygen and, importantly,
Oct-4 expression was unchanged during and after precondi-
tioning. These ﬁndings suggest the mild hypoxic treatment for
priming hESCs did not trigger a cascade leading to increased
cellular proliferation.
Preconditioned cells exhibited a signiﬁcantly higher per-
centage of NeuN-positive cells compared with normoxic
maintained controls. It is possible that enhanced neuronal
formation could be due to upregulation of hypoxia-responsive
genes, including tyrosine hydroxylase (TH).
32 Hypoxic culture
was shown to increase both the number of TH-positive
neurons and dopamine production from isolated rat mesen-
cephalic precursors.
25 Neuronal formation from telencephalic
precursors also increased in 3% oxygen, but neuronal
subtype changed from GABAergic to glutamatergic.
24 Addi-
tional data suggest that both the antiapoptotic gene Bcl-2 and
the angiogenic factors EPO and VEGF can enhance neuronal
protein expression and neurogenesis.
33,34 These ﬁndings
suggest that preconditioning may affect both the neurogenic
potential and neuronal subtype speciﬁcation from neural
precursors.
The necessity of HIF stabilization and downstream
effectors during hypoxia and preconditioning has been well
established.
35 Our datashowedthathypoxiastabilizedHIF1-a,
HIF2-a and Akt activation, followed by delayed upregulation
of EPO, VEGF and Bcl-2. VEGF activation and Akt
phosphorylation were required for neuronal survival after
preconditioning.
36 Recent work has begun to discern the
importance between HIF1-a and HIF2-a subunit expression
and target gene activation during neuronal cell death. HIF2-a
wasshowntodriveastrocyticexpressionofEPOandincrease
neuronal survival, whereas HIF1-a regulated VEGF and LDH
expression.
37 Similarly, conditional HIF1-a deletion caused
increased HIF2-a expression andEPO upregulation, suggest-
ing potential overlap in a-subunit function.
38 Future hypoxic
preconditioning studies on human neural precursor survival
should examine whether HIF1-a and/or HIF2-a stabilization
are required for enhanced cell survival.
In summary, we have demonstrated the directed neural
differentiation of the UCO6 hESC line and characterized the
functional maturation of hESC-derived neurons. Furthermore,
we have shown that brief exposure of human neural
precursors to sublethal hypoxia can attenuate cell death
induced by injurious events common to ischemic stress.
Preconditioning had no detrimental effect on neural differ-
entiation, neuronal function or proliferation. HIF stabilization
and activation of several key neuroprotective genes most
likely contribute tothe cytoprotection. Transplantingprecondi-
tioned cells may also improve endogenous neurogenic
and angiogenic responses within damaged tissue.
39 It is
thus suggested that hypoxic preconditioning represents a
clinically applicable regime to improve ES cell transplantation
therapies.
Materials and Methods
Human ES cell cultures. The UC06 human ES cell line (passages 45–70;
University of California at San Francisco) was expanded on a feeder layer
of mitotically inactivated MEFs in a growth medium of DMEM, 20% knockout
serum replacement (Invitrogen, Carlsbad, CA, USA), 2mM L-glutamine, 100mM
b-mercaptoethanol, 1% non-essential amino acids and 10ng/ml recombinant human
FGF-2 (R&D Systems, Minneapolis, MN, USA). To maintain pluripotency, colonies
were manually separated from feeder cells and morphologically identiﬁable
differentiated colonies. Passaging was performed every 3–5 days onto 60mm
dishes using a 20-gauge needle. The undifferentiated status of UCO6 colonies was
conﬁrmed through routine immunostaining for multiple pluripotent markers,
including Oct-4, SSEA4, tumor rejection antigen 1-60 (Tra-1-60) and Tra-1-81.
The karyotype of undifferentiated cells was determined every 10 passages to verify
the absence of chromosomal abnormalities. All research using hESCs adhered to
the guidelines established by the National Academy of Sciences.
Neural differentiation of the UCO6 hESC line. Neural differentiation
from manually isolated pluripotent UC06 colonies was achieved as previously
described by Itsykson et al.
22 Brieﬂy, undifferentiated hESC colonies were cultured
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Corning, NY, USA). The aggregates were maintained in neural precursor media
consisting of DMEM/F12, 1  B27 (Invitrogen), 2mM glutamine, 1  penicillin/
streptomycin and 20ng/ml FGF-2. To inhibit non-neural differentiation, aggregates
were also supplemented during the initial 21 days with 500ng/ml recombinant
mouse Noggin (R&D Systems). Media were changed every 3 days, during which
aggregates over 200mm in diameter were dissociated. After 42 days, aggregates
were partially dissociated through gentle trituration and plated on poly-D-lysine
(0.5mg/ml; MP Biomedical, Solon, OH, USA)/laminin (20mg/ml; BD Biosciences,
SanJose,CA,USA)coatedcoverslipsorchamberslidesforterminaldifferentiation.
Terminal differentiation was achieved by allowing plated cells to mature for up to 42
days without FGF-2 or Noggin supplementation.
Immunocytochemistry. Cells were ﬁxed with 4% paraformaldehyde (PFA)
for 15min and then permeabilized with 1% Triton X-100 for 10min. Coverslips were
then incubated in 5% normal horse serum (Invitrogen) for 1h before incubation with
primary antibodies overnight at 41C: 145kDa neuroﬁlament (MAB1621; 1:500),
MAP-2 (AB5622; 1:500), bIII-tubulin (MAB1637; 1:500), synaptophysin
(MAB5258; 1:1000), human nuclei (MAB1281; 1:100), NeuN (MAB377; 1:500),
O4 (MAB345; 1:25), MBP (AB980; 1:1000), GFAP (AB1540; 1:1000; Chemicon,
Billerica, MA, USA); NMDAR1 (05-432; 1:250; Upstate/Millipore, Billerica, MA,
USA);humannestin(MAB1259;1:500;R&DSystems).Followingprimaryantibody
incubation, cells were washed with 1  PBS, incubated with secondary antibody
Alexa Fluor 488-conjugated anti-rabbit or anti-mouse IgG, Cy3-conjugated
anti-mouse IgG, or Cy5-conjugated goat anti-rat IgG (Molecular Probes,
Invitrogen), washed and mounted with ProLong AntiFade (Invitrogen). Staining
was visualized by ﬂuorescent microscopy (BX61; Olympus, Tokyo, Japan).
For analysis of proliferation, cells were incubated overnight with the thymidine
analog BrdU (Sigma-Aldrich, St. Louis, MO, USA; 10mg/ml). Coverslips were then
washed with fresh neural precursor medium, ﬁxed in 4% PFA and immunostained
for human nestin. To quantifyBrdU incorporation, cells were again ﬁxedin 4% PFA,
washed, methanol ﬁxed for 14min and allowed to air-dry. After rehydrating with
PBS, coverslips were incubated with 2N HCl for 1h at 371C. Sections were treated
with 0.1M borate buffer at pH 8.4 for 10min, followed by 45min in 0.2% Triton
X-100. After blocking in 5% horse serum, cells were incubated with rat anti-BrdU
(1:500, Abcam, Cambridge, MA, USA) primary antibody overnight at 41C followed
by rinsing in PBS before incubation with Cy5 goat anti-rat IgG (1:500, Molecular
Probes, Invitrogen) secondary antibody for 1h at room temperature. Coverslips
were mounted with ProLong Antifade (Invitrogen) for visualization.
Whole-cell patch clamp recordings. Conventional whole-cell recordings
were performed in dissociated cells to record voltage-gated Na
þ and K
þ currents,
spontaneous mPSCs and ligand-gated NMDA or AMPA evoked currents. Brieﬂy,
coverslips containing neural-induced hESCs were placed on the stage of an
inverted microscope for patch clamp recordings using an EPC-9 ampliﬁer (HEKA,
Lambrecht, Germany). Recording electrodes of 6–15MO were pulled from Corning
Kovar Sealing #7052 glass pipettes by a Flaming-Brown micropipette puller
(Corning, NY, USA). The offset potential of the tip was routinely adjusted after
immersion into recording solution. All single measure receptor currents were
recorded at  70mV holding potentials. Recordings of mPSCs were performed at
 60mV holding potential. Currents and traces were acquired through the PULSE/
PULSEFIT program and ﬁltered at 3kHz by a 3-pole Bessel ﬁlter (HEKA).
Measurement of ligand-gated channel currents was achieved through use of the
VM8 voltage valve control drug delivery system (ALA Scientiﬁc Instruments,
Westbury, NY, USA). Recordings were performed at room temperature and pH
B7.3. Recording solutions used contained (in mM): NaCl 115, MnCl2 2, TEA 10,
HEPES 10, glucose 10 (external solution for inward Na
þ current); CsCl 130, NaCl
5, HEPES 10, BAPTA 1, TEA 6 (internal solution); NaCl 115, KCL 2.5, MnCl2 2,
HEPES 10, BAPTA 0.1, glucose 10, TTX 0.1mM (external solution for outward K
þ
current, mPSCs); KCl 120, MgCl2 1.5, Na2-ATP 2, CaCl2 1, BAPTA 1, HEPES 10
(internal solution); NaCl 120, KCl 3, CaCl2 2, HEPES 10, glucose 10, TTX 0.5mM
(external solution for NMDA, AMPA currents); CsCl 120 Na2-ATP 2, BAPTA 0.5,
HEPES 10.
Hypoxic preconditioning. Human ESCs in 100-mm dishes underwent
neuralinductionfor 42 daysbefore transplantation or invitroterminal differentiation.
For hypoxic preconditioning treatment, hESC aggregates of 41 days differentiation
were placed in a humidiﬁed chamber with 0.1–0.3% oxygen, 5% CO2 and balanced
nitrogenat 371C. Trypan blueexclusionassayshowedthatthe low O2 treatmentfor
up to 12h did not cause cell death. After 12-h hypoxic exposure, dishes were
removed and aggregates triturated and harvested for transplantation or plated on
35-mm coverslips or chamber slides for in vitro experimentation.
TUNEL staining. Both Trypan blue staining and TUNEL staining have been
used for detecting general cell death disregarding the death mechanism (apoptosis
and necrosis).
17,40 TUNEL staining, however, has the advantage of double staining
with another marker to reveal speciﬁc cell types of affected cells. TUNEL staining
was performed according to the manufacturer’s protocols (Promega, Madison, WI,
USA). Cells maintained on 12-mm coverslips were ﬁxed with 4% PFA, followed by
permeabilization with ethanol: acetic acid and 1% Triton X-100. Cells were then
incubated in equilibration buffer, followed by TdT enzyme incubation. After
conﬁrmation of positive TUNEL staining, cells were further immunostained for
human nestin and Hoechst. Total cell death was estimated using ImageJ software
(NIH,Washington,DC, USA) throughcomparison of TUNEL/Hoechst colocalization
versus all Hoechst-positive cells. To measure neural precursor cell death,
colocalization of TUNEL/nestin/Hoechst-positive cells was compared with all
nestin/Hoechst co-labeled cells.
Hydrogen peroxide and OGD insult. Non-preconditioned hESCs were
subjected to varying concentrations of H2O2 (0–10mM) to determine control cell
death. Cytoprotective effects of preconditioning were determined as follows: 12h
0.1% oxygen culture followed by 24–120h reoxygenation to allow upregulation of
cytoprotective compounds. After hypoxicculture andreoxygenation,preconditioned
hESCs and non-preconditioned hESCs were treated with H2O2 for 24h. Cells were
then ﬁxed by 4% PFA and TUNEL staining colocalized with Hoechst and nestin
used to determine total cell death and neural precursor cell death. To test for OGD
sensitivity, non-preconditioned hESCs and preconditioned hESCs were gently
washed twice in glucose-free DMEM/F12, followed by culture in 95% N2/5% CO2
and DMEM/F12 without glucose (US Biological, Swampscott, MA, USA) or B27 for
4h after 24–120h reoxygenation of HP human ESCs. Cell death was determined
through TUNEL staining colocalization with Hoechst and nestin.
Reverse transcriptase-polymerase chain reaction. RNA was
isolated from cell aggregates by the RNeasy RNA extraction kit (Qiagen,
Valencia, CA, USA). Complementary cDNA was formed from 0.250 to 1mg RNA
using Advantage RT for PCR protocol (Clontech, Mountain View, CA, USA). PCR
reactions using standard protocols with Taq DNA polymerase were performed on a
Px2Thermocycler(ThermoScientiﬁc,Waltham,MA,USA).Thefollowingconditions
were used: 941C 2min 45s, 50–601C4 5 s ,7 2 1C 10min, 25–30 cycles. PCR
products were visualized on a 2% agarose gel. The following primer sequences
were used: HIF1-a forward (F) – ctgaccctgcactcaatcaa, reverse (R) – tccatc
ggaaggactaggtg; BNIP3 F – agggctcctgggtagaactg, R – actccgtccagactcatgct; b-actin
F – agaaaatctggcaccacacc, R – ggggtgttgaaggtctcaaa.
Immunoblotting. Cells were collected by centrifugation or cell scraping,
and protein isolated with RIPA buffer containing protease inhibitor cocktail (Sigma-
Aldrich). Protein concentrations were determined using bicinchoninic acid assay
(BCA; Pierce, Rockford, IL, USA). Proteins were then separated by SDS-page gel
electrophoresis, followed by transfer to PVDF membrane (Biorad, Hercules, CA,
USA). Membranes were blocked for 1h with 5% BSA containing phosphatase
inhibitors (50mM NaF, 200mMN a 3VO4) before overnight incubation with primary
antibodies: VEGF (sc-507; 1:1000), Flk-1 (sc-6251; 1:1000), EPOR (sc-697;
1:1000), Akt (sc-8312; 1:1000), Bcl-2 (sc-7382; 1:500), Bcl-Xl (sc-8392; 1:500),
BDNF (sc-546; 1:1000), a-tubulin (sc-5286; 1:5000), EPAS-1 (sc-28706;
1:2000), EPO (sc-7956; 1:2000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), phospho-Akt (S473) (#9271; 1:1000), NF-E ˆB (#3035; 1:2000; Cell
Signaling Technology, Danvers, MA, USA), GLUT-1 (AB1340; 1:7500), 17kDa
Caspase3 (AB3623;1:2000), FGF-2(AB1458;1:500; Chemicon/Millipore),HIF1-
a (NB100-479; 1:2000; Novus Biologicals, Littleton, CO, USA), Bax (no. 54179;
1:500; Anaspec, Fremont,CA,USA). Blotswerewashed, antigenbindingdetectedby
incubation with anti-rabbit or mouse HRP-conjugated secondary antibodies (Biorad)
and detection by ECL method (Thermo Scientiﬁc). Chemiluminescence was detected
on CL-XPosure radiographic ﬁlms (Thermo Scientiﬁc) and intensity analyzed by
ImageJ software (NIH). To compare relative protein intensity across groups, loading
was normalized to either b-actin or a-tubulin expression before analysis.
Cell counting. Randomly selected ﬁelds from 12mm coverslips were imaged
at  20 and  40 magniﬁcation from at least three separate experiments.
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levels of proteins are based on Hoechst staining for total cell population.
Multinucleated clumps of cells were excluded from cell counting analysis.
Statistical analysis. Data were graphed and analyzed using either Prism
(GraphPad Software, San Diego, CA, USA) or SigmaPlot (SyStat Software, San
Jose,CA,USA)software.Student’stwo-tailedt-testwasusedforcomparisonoftwo
experimental groups. Multiple comparisons were performed using one-way ANOVA
followed by Tukey post-test. Signiﬁcance was determined based on standard error
of mean and deﬁned as Po0.05.
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